Weill Cornell Medicine, in collaboration with Columbia University Irving Medical Center and NewYork-Presbyterian, has been awarded a $900,000 grant from the U.S. Department of Defense (DoD) to conduct prostate cancer clinical trials.
When Dr. Olorunseun Ogunwobi, an associate professor of biology at Hunter College and adjunct assistant professor at Weill Cornell Medicine needed African-American men to participate in his research on how genetics might play a role in prostate cancer disparities, he reached out to a well-known Bronx community leader to help him establish relationships with potential participants.
